Icon

ZYMAR (nda021493)- (0.3%)

GATIFLOXACIN ALLERGAN
0.3%
Yes No
2020-Feb-20 Expired
None None
None No
ZYMAR® is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Haemophilus influenzae, Corynebacterium propinquum, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group, Streptococcus pneumoniae
0 1 0
Total Other Developers None
Drugs with Suitability No
0.3% ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.